David Gordon the Chief Corporate Office of PharmaCielo joined Business of Cannabis to talk about the company receiving authority to export CBD isolate from Colombia, their major increase in extraction capacity and their planned acquisition of Creso Pharma.
Next Thursday, 6 November 2025, Business of Cannabis: New York returns to The Wythe Hotel, Williamsburg, uniting more than 300...
Cannabis is now one of the most frequently discussed therapeutic agents in modern medicine, driven by expanding access programmes and...
Next Thursday, 6 November 2025, Business of Cannabis: New York returns to The Wythe Hotel, Williamsburg, uniting more than 300...
Cannabis is now one of the most frequently discussed therapeutic agents in modern medicine, driven by expanding access programmes and...
The European medical cannabis industry is continuing to mature, seeing companies focused on science-based research push the boundaries of our...
Airo Brands, a US multi-state CPG company focused on proprietary cannabis products, in partnership with Jupiter Research LLC, has received...
Oregon-based edibles company Grön has weighed in on the ongoing controversy surrounding New York’s so-called ‘rent-a-licence’ scandal. The dispute follows...
Cookies, the most globally recognised cannabis brand, is entering global medical markets with a full extract portfolio through a strategic...
Despite being the second-largest and one of the most mature medical cannabis markets in Europe, the UK still falls well...
Germany’s telemedicine-fuelled expansion has driven the value of its medical cannabis market up by hundreds of millions of euros in...
The medical cannabis industries in Australia and New Zealand are continuing to evolve rapidly, with both markets showing signs of...
Accredited Medical Cannabis Symposium Could ‘Benefit Thousands of Patients’, Says Expert
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
